News Releases
October 1, 2024
The following press release was distributed by the American Society for Radiation Oncology (ASTRO) Phase 2 clinical trial finds 177Lu-Dotatate may extend progression-free survival for[...]
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community